Takserman A - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.

Serebruany VL, Malinin AI, Sane DC, Jilma B, Takserman A, Atar D, Hennekens CH. Serebruany VL, et al. Among authors: takserman a. Eur J Pharmacol. 2004 Sep 24;499(3):315-24. doi: 10.1016/j.ejphar.2004.07.114. Eur J Pharmacol. 2004. PMID: 15381054 Clinical Trial.

Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.

Serebruany VL, Malinin AI, Oshrine BR, Sane DC, Takserman A, Atar D, Hennekens CH. Serebruany VL, et al. Among authors: takserman a. Thromb Res. 2004;113(3-4):197-204. doi: 10.1016/j.thromres.2004.03.002. Thromb Res. 2004. PMID: 15140583

Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans.

Atar D, Malinin A, Takserman A, Pokov A, van Zyl L, Tanguay JF, Lesperance F, Serebruany V. Atar D, et al. Among authors: takserman a. J Clin Psychopharmacol. 2006 Apr;26(2):172-7. doi: 10.1097/01.jcp.0000204047.76286.6e. J Clin Psychopharmacol. 2006. PMID: 16633147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters